Related Experiment Video
Updated: Jun 29, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Incidence of Hepatitis A in Argentina after vaccination
1ANLIS_National Institute of Epidemiology Dr. Juan H. Jara, Mar del Plata, Argentina. vacchinomarta@yahoo.com.ar
Insights
Argentina
Area of Science:
- Epidemiology
- Immunization Programs
- Public Health
Background:
- Hepatitis A incidence in Argentina was high (70.5-173.8 per 100,000) between 1995-2004.
- A universal, single-dose hepatitis A vaccination program for 12-month-old children began in June 2005.
Purpose of the Study:
- To evaluate the impact of universal hepatitis A vaccination in Argentina.
- To assess changes in disease incidence following the immunization program.
Main Methods:
- Longitudinal analysis of hepatitis A data from Argentina's National Notifiable Diseases Surveillance System (SINAVE).
- Comparison of 2007 incidence rates with the 1998-2002 pre-vaccination baseline period.
- Analysis by age group and geographical region.
Main Results:
- Overall hepatitis A incidence decreased by 88.0% in 2007 (10.2 per 100,000) compared to the baseline (P < 0.001).
- Significant reductions observed across all age groups, including 83.1% in 1-year-olds.
- Substantial declines noted in all Argentinian regions.
Conclusions:
- Universal, single-dose hepatitis A vaccination in infants significantly reduced disease rates in Argentina.
- Sustained monitoring is crucial to ensure continued vaccination coverage and maintain low incidence.
Abstract:
In Argentina, the annual incidence rate of reported hepatitis A disease ranged from 70.5 to 173.8 per 100,000 during 1995-2004. A single dose universal hepatitis A immunization program aimed at children aged 12 months was started in June 2005. The aim was to observe the impact of universal vaccination against hepatitis A in Argentina. A longitudinal analysis of hepatitis A rates reported in Argentina since 1995 to the National Notifiable Diseases Surveillance System (SINAVE). Incidence rates in 2007 were compared with those for the prevaccination baseline period (1998-2002), overall and by age group and geographical regions. Overall vaccine coverage in Argentina was 95% in 2006 for the single dose. After initiating the program, a sharp decrease in disease rates was observed. The annual incidence of 10.2 per 100,000 during 2007 represents 88.0% reduction with respect to the average incidence rate for the period 1998-2002 (P < 0.001). For children aged 1 year, an 83.1% reduction in disease was observed in 2007, compared with the baseline period (P < 0.001). Furthermore, a sharp decline was also observed in all other age groups 87.1% [2-4 years], 88.7% [5-9 years], 83.6% [10-14 years], 78.8% [15-49 years], 20.7% [>50 years]. Also important reductions were observed in all Argentinian regions. Following the implementation of universal hepatitis vaccination with a single dose to children at 12 months of age, hepatitis A rates have declined substantially in Argentina. Monitoring is needed to verify that vaccination continues to proceed and that low rates are sustained.
Related Concept Videos
Vaccinations
Hepatitis
Viral Hepatitis I: Introduction
Chickenpox
Yellow Fever
Vaccines
